Dendritic cell-based immunotherapy induces transient clinical response in advanced rat fibrosarcoma - Comparison with preventive anti-tumour vaccination

Folia Biologica

Volumn 55, Issue 4, 2009, Pages 119-125

  Kucera A ^a   Pycha K ^a   Pajer, P ^b   Špíšek, Radek ^a   Skaba R ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

Cancer immunotherapy; Chemotherapy; Dendritic cells; Immunotherapy

Indexed keywords

CANCER ANTIBODY; DENDRITIC CELL VACCINE; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; FIBROSARCOMA; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RAT; T LYMPHOCYTE; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH;

ANIMALIA; RATTUS;

ANIMALS; CANCER VACCINES; CELL DEATH; CELL LINE, TUMOR; DENDRITIC CELLS; FIBROSARCOMA; IMMUNOTHERAPY; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; VACCINATION;

EID: 69749126995     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Antonia, S. J., Mirza, N., Fricke, I., Chiappori, A., Thompson, P., Williams, N., Bepler, G., Simon, G., Janssen, W., Lee, J. H., Menander, K., Chada, S., Gabrilovich, D. I. (2006) Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. Clin. Cancer Res. 12, 878-887.
2. Aspord, C., Pedroza-Gonzalez, A., Gallegos, M., Tindle, S., Burton, E. C., Su, D., Marches, F., Banchereau, J., Palucka, A. K. (2007) Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J. Exp. Med. 204, 1037-1047.
3. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
4. Berard, F., Blanco, P., Davoust, J., Neidhart-Berard, E.-M., Nouri-Shirazi, M., Taquet, N., Rimoldi, D., Cerottini, J. C., Banchereau, J., Palucka, K. A. (2000) Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J. Exp. Med. 192, 1535-1544.
5. Blattman, J. N., Greenberg, P. D. (2004)Cancer immunotherapy: a treatment for the masses. Science 305, 200-205.
6. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., Schreiber, R. D. (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991-998.
7. Dunn, G. P., Old, L. J., Schreiber, R. D. (2004a) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137-148.
8. Dunn, G. P., Old, L. J., Schreiber, R. D. (2004b) The three Es of cancer immunoediting. Annu. Rev. Immunol. 22, 329-360.
9. Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., Zitvogel, L. (2005) Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med. 202, 919-929.
10. Gilboa, E. (2004) The promise of cancer vaccines. Nat. Rev. Cancer 4, 401-411.
11. Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., Schreiber, R. D. (2007) Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903-907. (Pubitemid 350231320)
12. Marincola, F. M., Jaffee, E. M., Hicklin, D. J., Ferrone, S. (2000) Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 74, 181-273.
13. Masse, D., Ebstein, F., Bougras, G., Harb, J., Meflah, K., Gregoire, M. (2004) Increased expression of inducible HSP70 in apoptotic cells is correlated with their efficacy for antitumor vaccine therapy. Int. J. Cancer 111, 575-583. (Pubitemid 39045325)
14. Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., Métivier, D., Larochette, N., van Endert, P., Ciccosanti, F., Piacentini, M., Zitvogel, L., Kroemer, G. (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13, 54-61.
15. Rosenberg, S. A., Yang, J. C., Restifo, N. P. (2004) Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10, 909-915.
16. Spisek, R., Chevallier, P., Morineau, N., Milpied, N., Avet-Loiseau, H., Harousseau, J. L., Meflah, K., Gregoire, M. (2002) Induction of leukemia-specific cytotoxic response by cross presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin. Cancer Res. 62, 2861-2868. (Pubitemid 34525772)
17. Spisek, R., Brazova, J., Rozkova, D., Zapletalova, K., Sediva, A., Bartunkova, J. (2004) Maturation of dendritic cells by bacterial immunomodulators. Vaccine 22, 2761-2768. (Pubitemid 38900652)
18. Spisek, R. (2006) Immunoprevention of cancer: time to reconsider timing of vaccination against cancer. Expert Rev. Anticancer Ther. 6, 1689-1691.
19. Spisek, R., Dhodapkar, M. V. (2006) Immunoprevention of cancer. Hematol. Oncol. Clin. North Am. 20, 735-750.
20. Spisek, R., Dhodapkar, M. V. (2007) Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells. Cell Cycle 6, 1962-1965. (Pubitemid 47327881)
21. Spisek, R., Charalambous, A., Mazumder, A., Vesole, D. H., Jagannath, S., Dhodapkar, M. V. (2007) Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood 109, 4839-4845. (Pubitemid 46827780)
22. Steinman, R. M., Banchereau, J. (2007) Taking dendritic cells into medicine. Nature 449, 419-426.
23. Tobiasova, Z., Pospisilova, D., Miller, A. M., Minarik, I., Sochorova, K., Spisek, R., Rob, L., Bartunkova, J. (2007) In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients. Clin. Immunol. 122, 18-27.
24. Wheeler, C. J., Das, A., Liu, G., Yu, J. S., Black, K. L. (2004) Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clin. Cancer Res. 10, 5316-5326.
25. Yu, J. S., Wheeler, C. J., Zeltzer, P. M., Ying, H., Finger, D. N., Lee, P. K, Yong, W. H., Incardona, F., Thompson, R. C., Riedinger, M. S., Zhang, W., Prins, R. M, Black, K. L. (2001) Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res. 61, 842-847. (Pubitemid 32175145)
26. Zitvogel, L., Apetoh, L., Ghiringhelli, F., Kroemer, G. (2008) Immunological aspects of cancer chemotherapy. Nat. Rev. Immunol. 8, 59-73.